Stomach Cancer Market opportunities are expanding with the development of novel anticancer drugs and combination treatment strategies. Research into chemotherapy, immunotherapy, targeted therapies, and multimodal treatment approaches is creating opportunities for pharmaceutical innovation. The Stomach Cancer Market is expected to reach US$ 12,541 million by 2031, registering a CAGR of 14.9%...